Venture Capital Is Discovering Fashion Tech

The Fashion AI Expo’s launch at Paris Fashion Week 2026 is both a milestone and a symbol. It reflects the degree to which technology startups have moved from the periphery to the center of the industry’s most important event. Whether measured by media …

Will The Iran Conflict Reshape Venture Capital?

The U.S.-Israeli offensive against Iran has sent a jolt through global markets, but inside Silicon Valley’s deal rooms, the calculus is more nuanced. Defense tech is booming, MENA deals are slowing, and cybersecurity founders are fielding term sheets f…

How Global Conflicts Are Reshaping The Startup Playbook

As the war in Iran begins to disrupt markets and capital flows, founders and small businesses must adapt and integrate smarter risk management.

Work Waste Is The Hidden Tax On The AI Economy

Companies rushing to adopt AI face hidden costs in “work waste.” The article explores how workflow intelligence tools like Scribe reveal and fix this inefficiency.

Recruiting Is The New Marketing: Inside AI’s Talent War

As AI funding surges, startups are competing for engineers in public — making hiring their most strategic growth weapon.

How Venture Capital Is Rewiring Fashion From The Fiber Up

From potato-stem cotton substitutes to hemp-based loungewear, a new wave of investors is betting billions on the idea that your clothes should not poison you or the planet.

The Real Gender Gap In Startups Is About Ownership, Not Pay

Women CEOs are closing the pay gap in startups, but ownership still lags—especially in life sciences, where equity determines long-term wealth.

Who Is Winning Continuous Hormone Monitoring And What Comes Next

For decades, a blood draw in a clinical lab was the only way to quantify your hormones. In 2026, that paradigm is shifting and we are seeing saliva cartridges analyzed by smartphone AI, DNA-based biosensor patches, earring-back wearables, and sweat sensors are converging to make hormone tracking as routine as measuring heart rate. The market, valued at $325.7 million in 2025 and projected to reach $716.2 million by 2035, is opening up to a broader hormonal health market representing an estimated $600 billion opportunity The filed is now bubbling up with cohorts of academic breakthroughs, deep tech hardware bets, and AI platforms that are changing how we might be measing hormones in years to come.

The AI Megacycle: Five Forces Reshaping The Venture Market In 2026

AI’s 2026 megacycle is concentrating capital, compressing startup growth, reshaping IPO and forcing new monetization models that reward durable, AI native advantages.

The Hard Work Behind The“Yes”: How To Balance Consensus And Conviction

Explore how leading VCs build informed judgment, back non-obvious founders, and design cultures that protect outliers turning ambiguity into long-term impact.